With this purpose, CCL11/eotaxin, CXCL-10/IP-10, CCL2/MCP-1, and CCL4/MIP-1β levels were measured in the CSF of 87 PD patients (16 with dementia diagnosis) and 33 controls. Here, CCL2 is linked to Parkinson disease.